United States
Print page content Print
Increase text size Decrease text size
Text Size

Temaril P® (trimeprazine with predisolone)

Relieves itching and inflammation associated with pruritis

TEMARIL-P is indicated for dogs to relieve itching regardless of the cause. Its synergistic combination of antihistamine and corticosteroid may allow for lower doses of corticosteroids.1

TEMARIL-P has demonstrated relief of itching and the reduction of inflammation commonly associated with most skin disorders of dogs, such as the eczema caused by internal disorders, otitis and dermatitis (allergic, parasitic, pustular and nonspecific).

TEMARIL-P has been found to be effective therapy and adjunctive therapy in various cough conditions of dogs. Therefore, in addition to its antipruritic action, TEMARIL-P is recommended for the treatment of “kennel cough” or tracheobronchitis, bronchitis including all allergic bronchitis, and infections and coughs of nonspecific origin.

 

Expand All
    • Provides a 3-way therapeutic effect—antipruritic, antitussive and anti-inflammatory
    • May allow for lower doses of corticosteroid to be administered in some cases due to synergistic combination of an antihistamine and a corticosteroid1
    • Relieves intense itching caused by allergic, inflammatory and parasitic dermatoses
    • Relieves itching and reduces inflammation associated with most common dermatologic disorders in dogs, including otitis
    • Provides relief from coughing associated with “kennel cough,” bronchitis, allergies or nonspecific causes
    1. Paradis M, Scott DW, Giroux D. Further investigations on the use of nonsteroidal and steroidal anti-inflammatory agents in the management of canine pruritus. J Am Anim Hosp Assoc. 1991;27:44-48.


IMPORTANT SAFETY INFORMATION: Do not use TEMARIL-P in animals with tuberculosis, peptic ulcer, and Cushing’s syndrome. Use with extreme caution in pregnant animals. Watch for evidence of concurrent infection.

For more safety information, please refer to the full Prescribing Information.